| 000 | 01481 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518071806.0 | ||
| 264 | 0 | _c20200413 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1422-0067 | ||
| 024 | 7 |
_a10.3390/ijms20235831 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNinčević, Vjera | |
| 245 | 0 | 0 |
_aRenal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes. _h[electronic resource] |
| 260 |
_bInternational journal of molecular sciences _cNov 2019 |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 _xmetabolism |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 700 | 1 | _aOmanović Kolarić, Tea | |
| 700 | 1 | _aRoguljić, Hrvoje | |
| 700 | 1 | _aKizivat, Tomislav | |
| 700 | 1 | _aSmolić, Martina | |
| 700 | 1 | _aBilić Ćurčić, Ines | |
| 773 | 0 |
_tInternational journal of molecular sciences _gvol. 20 _gno. 23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/ijms20235831 _zAvailable from publisher's website |
| 999 |
_c30342066 _d30342066 |
||